Parsippany-based Teva reaches $225M opioid settlement with Texas - NJBIZ
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Reuters Spotlight on Kåre Schultz, CEO Teva Pharmaceuticals - YouTube
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Kåre Schultz - President & CEO at Teva Pharmaceutical Industries | The Org
Teva CEO steps down, replacement found
Teva denies outgoing CEO board role
Teva names Lundbeck's Kåre Schultz as President and Chief Executive Officer - PharmaTimes
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Watch CNBC's full interview with Teva CEO Kåre Schultz
A Look At Kare Schultz, The New CEO In Charge Of Teva
Cephalon's CEO vs Kåre Schultz | Comparably
Lundbeck CEO Kåre Schultz comments on Lundbeck's 2017 H1 Results - YouTube
Where is Kåre Schultz? | Ctech
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva's shares surge as first quarter results beat expectations | The Times of Israel
